NM_005249.5:c.256C>A
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BS2BP4
This summary comes from the ClinGen Evidence Repository: The p.Gln86Lys variant is observed in at least 2 unaffected individuals (internal database) (BS2). Computational analysis prediction tools suggest that the p.Gln86Lys variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). The p.Gln86Lys variant in FOXG1 is absent from gnomAD (PM2_Supporting). In summary, this variant meets the criteria to be classified as likely benign. Although there are both pathogenic and benign types of evidence for this variant, the pathogenic evidence is not considered inconsistent with the final classification. ACMG/AMP criteria applied, as specified by the ClinGen Rett/Angelman-like expert panel: BS2, BP4 (approved 8/25/22). LINK:https://erepo.genome.network/evrepo/ui/classification/CA222854/MONDO:0100040/016
Frequency
Consequence
NM_005249.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FOXG1 | ENST00000313071.7 | c.256C>A | p.Gln86Lys | missense_variant | Exon 1 of 1 | 6 | NM_005249.5 | ENSP00000339004.3 | ||
| FOXG1 | ENST00000706482.1 | c.256C>A | p.Gln86Lys | missense_variant | Exon 2 of 2 | ENSP00000516406.1 | ||||
| LINC01551 | ENST00000675861.1 | n.374+1522C>A | intron_variant | Intron 1 of 3 |
Frequencies
GnomAD3 genomes AF: 0.00000678 AC: 1AN: 147538Hom.: 0 Cov.: 31 show subpopulations
GnomAD4 exome AF: 0.00000107 AC: 1AN: 934236Hom.: 0 Cov.: 18 AF XY: 0.00000227 AC XY: 1AN XY: 439890 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000678 AC: 1AN: 147538Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 71806 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
FOXG1 disorder Benign:1
The p.Gln86Lys variant is observed in at least 2 unaffected individuals (internal database) (BS2). Computational analysis prediction tools suggest that the p.Gln86Lys variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). The p.Gln86Lys variant in FOXG1 is absent from gnomAD (PM2_Supporting). In summary, this variant meets the criteria to be classified as likely benign. Although there are both pathogenic and benign types of evidence for this variant, the pathogenic evidence is not considered inconsistent with the final classification. ACMG/AMP criteria applied, as specified by the ClinGen Rett/Angelman-like expert panel: BS2, BP4 (approved 8/25/22). -
Rett syndrome, congenital variant Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at